|Videos|November 11, 2022
Evolution of SARS-CoV-2 Variants on Booster Shot Development and Formulations
Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc, leads a discussion on the constant evolution of SARS-CoV-2 variants and the impact on vaccine and booster shot development and administration.
Advertisement
Episodes in this series
Advertisement
Related to this article
Two IDWeek 2026 studies link influenza vaccination to fewer ICU admissions in older adults and fewer emergency visits in children.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cystatin C and the Future of Kidney Function Assessment
2
Medicare GLP-1 Bridge Runs Outside Part D and Pharmacy Teams Need a Different Workflow
3
GLP-1 RAs, Finerenone, and CKD: Key Data From Kidney Week 2026
4
FDA Approves Talazoparib With Enzalutamide for HRR-Mutated Metastatic Prostate Cancer
5